TRAX
First Tracks Biotherapeutics, Inc. · Healthcare · Market cap $1.5B
Insiders sold $1.8M net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Sep 4, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$66.8M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Sep 4, 2026
Ware J. Anthony
First Tracks Biotherapeutics, Inc. (TRAX) has 9 SEC Form 4 filings (10 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Sep 4, 2026.
Inside the rolling window, 2 insiders at First Tracks Biotherapeutics, Inc. reported no open-market purchases and 2 open-market sales totaling $66.8M. Insiders have net sold $66.8M over the trailing 6 months. The most recent open-market filing is a sale of 39,265 shares by Director Ware J. Anthony, dated Sep 2, 2026, worth $1.8M.
- Industry:Biotechnology
- CEO:Daniel R. Faga
- Employees:104
- HQ:San Diego, CA, US
- IPO:2026-04-20
| Source | |||||||
|---|---|---|---|---|---|---|---|
Ware J. AnthonyFirst in 9 months | Director | Sale | 39,265 | $1.8M | Sep 4 | +3.3% | SEC ↗ |
EcoR1 Capital, LLCFirst in 3 months | 10% Owner | Sale | 4,705,575 | $65.0M | Apr 22 | +121.5% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does TRAX have?
First Tracks Biotherapeutics, Inc. (TRAX) has 9 SEC Form 4 filings (10 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Sep 4, 2026.
When was the most recent SEC Form 4 filing for TRAX?
The most recent Form 4 filing for TRAX on Tracefour is dated Sep 4, 2026.
What is the net insider flow at TRAX over the last 6 months?
Over the trailing 180 days, insiders at TRAX have net sold $66.8M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at TRAX in the current window?
Inside the rolling window, insiders at TRAX bought $0 and sold $66.8M based on SEC Form 4 filings.
Can I get alerts for TRAX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at First Tracks Biotherapeutics, Inc. (TRAX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
First Tracks Biotherapeutics, Inc. is in the Healthcare sector.